1H,1H,2H,2H-Nonafluorohexyl Methacrylate (stabilized with TBC)>98.0%(GC)5g

Ravoxertinib, 99.75%, 250mg

2,6-Bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[1,2-b:4,5-b']dithiophene, 95+%, 250mg

N,3-Dimethylbutan-1-amine hydrochloride, 97%, 250mg

tert-Butyl 2-(cyanomethyl)piperazine-1-carboxylate, 98%, 500mg

1,2-BIS((2R,5R)-2,5-DIETHYLPHOSPHOLAN-1-YL)BENZENE, 98%, 250mg

3-Methoxy-2,2-dimethyl-3-oxopropanoic acid, 95.0%, 5g

5-Methyl-1,3,4-oxadiazol-2(3H)-one, 95.0%, 250mg

H-DL-Val-OMe.HCl, 98%, 5g

3-(6-Ethoxy-pyrimidin-4-ylamino)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

Methyl 3-methylenecyclobutanecarboxylate, 95.0%, 1g

2,4-Bis[(dodecylthio)methyl]-6-methylphenol>95.0%(GC)500g

2,6-DICHLORO-5-METHYL-1H-1,3-BENZODIAZOLE, 95.0%, 250mg